摘要
目的观察水飞蓟宾治疗脂肪肝的疗效。方法选取脂肪肝患者72例,随机将其均分为观察组与对照组。对照组给予口服还原型谷胱甘肽片治疗,观察组给予水飞蓟宾治疗,疗程为12周。结果观察组治疗总有效率为95.0%,对照组治疗总有效率为71.9%,组间差异有统计学意义(P<0.05);结论水飞蓟宾应用于脂肪肝疗效较好,可改善肝功能,降血脂,优于对照组,疗效确切,应用安全。
Objective To observe the therapeutic effect of silymarin on cases with fatty liver disease.Methods 72 cases with fatty liver disease were randomly divided into treatment groups and control groups,oral administration of silybin capsules and oral reduced glutathione were taken for treatment and control group,respectively,with the treatment course as 12 weeks.Results Total effective rate in the treatment group was 95.0%,the control group was 71.9%,with signifi cant difference（P〈0.05）.Conclusion Silibinin capsule has a positive curative effect on liver function recovery and blood lipids for alcoholic fatty liver patients,which signifi cantly better than the control group,with good efficacy and application security.
出处
《中国继续医学教育》
2015年第17期147-148,共2页
China Continuing Medical Education
